欧洲医药市场 Omega-3 成分 - 行业趋势和 2030 年预测

欧洲医药 Omega-3 成分市场分析及规模

老年人口预计将为降低胆固醇和改善心脏健康的产品创造机会，尤其是在欧洲。目前，正在进行大量研究，预计这将为多家制造商创造竞争优势，以开发用于药品的新型创新 omega-3 成分。欧洲生活方式和与年龄相关的疾病日益增多，因此促进了补充剂和功能性食品领域的增长，收入份额为 52%。

 Data Bridge Market Research 分析了 2023-2030 年预测期内医药市场 omega-3 成分的增长率。在上述预测期内，医药市场 omega-3 成分的预期复合年增长率约为 10.5%。2022 年市场价值为 1.5812 亿美元，到 2030 年将增长至 3.5147 亿美元。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。

欧洲医药用 Omega-3 成分市场范围和细分

Market Definition

Omega 3 ingredients are naturally occurring polyunsaturated fatty acids and nutrients that are essential for optimal human health. There are three kinds of omega 3 ingredients, namely, eicosapentaenoic acid (EPA), alpha-linoleic acid (ALA), and docosahexaenoic acid (DHA). EPA and DHA are mostly extracted from fish and ALA is mainly extracted from plants sources such as seeds and nuts.

Europe Omega-3 Ingredients for Pharmaceuticals Market Dynamics

Drivers

• Increasing Demand of Docosahexaenoic acid (DHA)

Docosahexaenoic acid (DHA) type is in higher demand due to the increasing utilization of the product in infant formulas for the betterment of the overall health of an infant. In the human diet, DHA is the most vital and abundant omega-3 fatty acid, which helps in maintaining the overall health of the human body. DHA is a main component for the development and maturity of an infant's brain and eyesight. Furthermore, it is extensively used in nutritional supplements and fortified foods. It is also widely used in treating dementia, coronary artery disease (CAD), attention deficit hyperactivity disorder, and Type 2 diabetes. DHA helped in increasing f longevity have also resulted in its use in elderly nutrition products. Thus, this factor increases the growth of the market.

• Rising Consumption of Omega-3 Supplements Among Adult Consumers

Omega-3 fatty acids, mainly EPA and DHA, are required in the human diet for proper growth, development, and good health. These have been found to be very beneficial for heart health, joint and inflammation support, cognitive function, eye health, pregnancy and healthy child development, and immune function, among other benefits. Also, algae omega-3 ingredients used in dietary supplements, with the primary focus of EPA-only products, will be the future focus of the market in the region. Also, consumers are looking for several new developments in omega-3 products and their focus on particular health benefits. The benefits of omega-3s in protecting adult eyes from age-related macular degeneration and dry eye syndrome are also influencing the market growth. This factor improves the market growth.

Opportunities

• Huge growth in concentrated forms of algal omega-3 ingredients

New ultra-high concentrated omega-3 ingredients offer several benefits to consumers willing to pay a higher premium price for high-end products. Several suppliers are investing in the production of high concentrated algal omega-3 products, estimating increased demand to drive the sales. The market for concentrates has also been increasing, as more consumers become aware of the benefits of algal omega-3 and seek the benefits of higher doses. Several major companies are involved in omega-3 manufacturing that has started to strategically capitalize the existing business expansion opportunity.

• Increasing Research Activities

Numerous research studies have developed a link between consumption of fatty fish and lowering of coronary heart diseases. For instance, fish oils are widely used as a supplement to balance the required dietary intake of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Furthermore, several local players, such as Pharma Nord, have launched mega-3 dietary supplements targeting varied sets of population. For instance, the company’s pure and natural fish oil in capsules which are widely available in a natural lemon flavor, is targeted toward children to increase their health benefits, thus leading to its increased purchases by parents. Thus, this factor helps to create much opportunities for the growth of the market.

Restraints/Challenges

• Side Effects of omega-3 ingredients

There are various side-effects associated with the omega-3 ingredients for pharmaceuticals. Effects such as burping, diarrhea, heartburn, joint pain, stomach pain or discomfort, vomiting, constipation, nausea. Thus, these adverse effects affect the growth rate by decreasing the adoption of omega-3. This impedes the market growth.

• Increasing Negative Consumer Perception About omega-3 ingredients

Negative consumer perception associated with the smell and taste of omega-3 ingredients is also anticipated to limit the growth of the market. These unstable fatty acids can damage through enzymatic or chemical oxidation to form compounds that give foods a fishy smell. Additionally, fresh fish oil has no fishy taste or smell, just like fresh fish. People feel hesitant to adopt for omega-3 ingredients. Thus, this hampers the market growth.

这份用于药品的 omega-3 成分市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响，分析了新兴收入来源、市场法规变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新等方面的机会。如需了解有关用于药品的 omega-3 成分市场的更多信息，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您做出明智的市场决策，实现市场增长。

近期发展

• 2021 年，Omega-3 相关供应商 GC Rieber VivoMega 宣布计划在未来几年增强生产设施和储存罐，以容纳更多成分。
• 2021 年，KD Pharma Group 推出了 Alga3，一种可持续的纯素 Omega-3 解决方案。KD Nutra 的卓越技术和生产灵活性使其能够生产出种类繁多的 Omega-3 浓缩物。该公司可以根据客户需求定制 EPA 和 DHA 比例，并且对于任何 kd-pür 鱼油，都有与之匹配的 Alga3 植物基解决方案。
• 2021 年，AlgaeCytes Limited 宣布计划在德国萨克森-安哈尔特州德绍建造其第一家商业工厂。该工厂将由该公司的德国子公司 AlgaeCytes Germany GmbH 拥有和运营。

欧洲 Omega-3 医药原料市场范围

医药用 Omega-3 成分市场根据来源、类型、形式、治疗领域、人口类型和分销渠道进行细分。这些细分市场之间的增长将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。

来源

• 海洋
• 植物

类型

• 二十二碳六烯酸 (DHA)
• 二十碳五烯酸(EPA)
• 亚麻酸 (ALA)

表格

• 液体
• 干燥

治疗领域

• 心血管疾病
• 自身免疫性疾病
• 骨骼和关节疾病
• 神经系统疾病
• 眼科疾病
• 皮肤健康
• 癌症
• 其他的

人口类型

• 成年人
• 孩子们

分销渠道

• 直接的
• 间接

医药市场 Omega-3 成分区域分析/见解

对药品市场的 Omega-3 成分进行了分析，并按来源、类型、形式、治疗领域、人群类型和分销渠道提供了市场规模洞察和趋势。

药品 Omega-3 成分市场报告涉及的主要国家 有德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其和欧洲其他地区。

由于藻类 EPA 成分和强化产品的增加，德国在预测期内见证了用于药品市场的 Omega-3 成分的积极增长。英国政府已将成人日常饮食中 EPA 和 DHA 的推荐摄入量从 200 毫克提高到 450 毫克。英国的消费模式有所不同，只有 27% 的人食用油性鱼，大多数成人和儿童依赖补充膳食产品中的其他来源的 EPA 和 DHA。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。此外，在提供国家数据预测分析时，还考虑了欧洲品牌的存在和可用性以及它们因来自本地和国内品牌的激烈竞争或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

竞争格局和欧洲 Omega-3 医药原料市场份额分析

药品用 Omega-3 成分市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、欧洲业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对药品用 Omega-3 成分市场的关注有关。

药品 Omega-3 成分市场的主要参与者包括：

• Avestia Pharma（印度）
• Novasep（法国）
• AbbVie Inc.（美国）
• KD制药集团（日本）
• 巴斯夫公司（德国）
• Corbion（荷兰）
• 帝斯曼（荷兰）
• 阿斯利康（英国）
• 葛兰素史克公司（英国）
• 费森尤斯卡比公司（德国）
• Croda International Plc（美国）
• AMARIN CORPORATION（爱尔兰）
• ANI Pharmaceuticals, Inc.（美国）
• Epax（挪威）
• Strides Pharma Science Limited（印度）
• Pharma Marine AS（挪威）
• KinOmega Biopharm Inc. (中国)
• Camber Pharmaceuticals, Inc.（美国）

SKU-55584